SYRS Syros: Margin dodolan resik

syros.com (SYRS) - logo korporat

The primary driver for Syros Pharmaceuticals (SYRS) is its gene management platform for cancer therapy, which generates cash flow through patent agreements. The net operating margin illustrates this trend, where 0.00 characterizes this valuation parameter. Future prospects depend on the results of oncology trials, while potential demand is driven by the shortage of effective treatments for complex leukemias.

syros.com (SYRS) - Margin resik saka 04.07.2022 nganti 29.03.2025

Syros - rincian analitis lan metrik utama (SYRS)

- rega saham lan prakiraan rega para ahli:
Analisis kabeh metrik perusahaan:Syros Pharmaceuticals Inc. - SYRS
Produk dadi Syros Pharmaceuticals Inc.

For Syros Pharmaceuticals (SYRS), which develops targeted leukemia therapy based on genomic analysis, sales margins determine the financial stability of the innovation cycle. This metric is calculated as the ratio of net income to total revenue, measuring the portion of profit derived from every dollar of revenue. The trend in net income per unit of revenue reflects the efficiency of R&D cost management. It is critical for investors to track this trend to assess operating leverage. An increase in this indicator signals a transition from cost-intensive development to the commercial monetization of the drug.

Pesaing utama

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|CRSP - Margin resik|GeneDx - Rentabilitas dodolan miturut bathi resik|Tingkat bathi resik RARE|Beam Tx - Margin dodolan resik|SRPT - Margin dodolan resik|TWST (Twist Bio) - Rentabilitas dodolan miturut bathi resik|Rentabilitas dodolan resik TXG|Rentabilitas dodolan miturut bathi resik NTLA|Stoke Therapeutics Inc (STOK) - Margin dodolan perusahaan|Margin dodolan resik BLFS|Margin resik WVE (Wave Life Sciences Corp)|Margin resik Maze Therapeutics MAZE|Tingkat bathi resik SION|PRME - Margin resik|Margin dodolan perusahaan Taysha TSHA|QURE: Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Margin dodolan resik|solidbio.com (SLDB) - Margin dodolan perusahaan|Margin resik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Rentabilitas dodolan resik|Benitec Biopharma - Rentabilitas dodolan miturut bathi resik|DSGN: Rentabilitas dodolan resik|RCKT: Rentabilitas dodolan miturut bathi resik|FDMT - Margin dodolan resik|LXEO: Margin dodolan resik|Korro Bio Inc. - Tingkat bathi resik|EDIT (editasmedicine.com) - Margin dodolan resik|Margin resik SLN|Margin resik ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan resik|Margin resik Sangamo SGMO|NAUT: Rentabilitas dodolan resik|MGX: Rentabilitas dodolan miturut bathi resik|Margin resik Precision BioSciences|GBIO (generationbio.com) - Rentabilitas dodolan miturut bathi resik|Margin resik boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin dodolan resik|Rentabilitas dodolan resik IMNN (Imunon, Inc.)|Margin dodolan resik PHIO|MBIO - Margin resik|Margin dodolan resik RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin resik|Applied DNA - Margin dodolan resik|Margin resik Bluebird Bio|ImmunoPrecise (IPA) - Margin resik|Margin bathi resik OMGA (Omega)|Margin resik Singular Genomics Systems|Margin resik regulusrx.com RGLS|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX